Company: PFSA
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-073872
Chunk: 165

Company: Profusa, Inc.
Filing Date: 2025-08-11
Form: S-1
Chunk 165
---
 commercialization and wide -scalemarketing for our Lumee Oxygen and Lumee Glucose devices. Our future capital requirements will depend on many factors, including our revenue growth rate, the timing and the amount of cash received from our customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts. In the future, we may enter into arrangements to acquire or invest in complementary businesses, products, and technologies. For any periods after the twelve months subsequent to the filing of these financial statements as of June30, 2025, we may be required to seek additional equity or debt financing. In the event that we require additional financing we may not be able to raise such financing on acceptable terms or at all. If we are unable to raise additional capital or generate cash flows necessary to continue our research and development and invest in continued innovation, we may not be able to compete successfully, which would harm our business, results of operations, and financial condition. If adequate funds are not available, we may need to reconsider our production investments, the pace of our production ramp -up, expansion plans or limit our research and development activities, which could have a material adverse impact on our business prospects and results of operations. Cash Flow Summary The following table summarizes our cash flows for the periods presented (in thousands):

| 2025                            
 Net cash provided by (used in): |     | Three Months Ended 
 March 31,          |      | 2024 |     |   |      |   |
|:--------------------------------|:----|:-------------------|-----:|:-----|:----|:--|-----:|:--|
| Operating activities            |     | $                  | (537 | )    |     | $ | (742 | ) |
| Investing activities            |     | $                  |    — |      |     | $ |    — |   |
| Financing activities            |     | $                  |  365 |      |     | $ |  610 |   |

Operating Activities Cash used in operating activities for the three months ended March 31, 2025 of $0.5 million was primarily driven by our net loss of $2.7 million, adjusted for non -cashcharges of $1.3 million and net cash inflows of $0.9 million provided by changes in our operating assets and liabilities. Non -cashcharges primarily consisted of non -cashinterest expense of $1.2 million, and the change in the fair value of related party convertible loan